Most Active Kidney Investors, By Stage & Segment

Kidney Capital: Who’s Funding the Future of Kidney Care?

This snapshot explores the most active investors shaping the Kidneyverse, from accelerators to IPO-stage backers. It highlights the "who," "what," and "why" behind kidney care funding:

• Who & When: Meet 14 of the most active investors across 4 key lifecycle stages: accelerators, early-stage VC, growth equity, and strategic capital.
• What: Investments span 4 core segments – care delivery, devices, diagnostics, and more – with clear distinctions between funding, M&A, and exits.
• Why: Uncover the signals behind investments, exits, and the timing that shapes innovation in kidney care.

Explore the Signals:

1. CVS wants to deliver care… everywhere
2. Baxter is about to make its biggest bet ever
3. YC is picking up the pace on its bio x health bets
4. Public investments work: KidneyX and America’s Seed Fund
5. Death Valley: what happens to accelerate-ed MedTech startups?

Connect & Share

This graphic is free to download as part of my mission to make kidney care more accessible and actionable for innovators around the world. If you find this content helpful, please consider sharing Signals with 1 or 2 friends in the Kidneyverse.

About me & signals

I'm Tim Fitzpatrick. By day, I'm building IKONA; by night, I write Signals— curating & sharing lessons from the frontiers of kidney innovation, one [space] at a time. My goal is to make the frontiers of health more accessible, actionable, and backable, one [space] at a time.